AbbVie notched a win late last month in its ongoing battle against thousands of lawsuits that claim AndroGel, a once-blockbuster drug marketed to treat low testosterone in men, causes heart attacks, ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
AbbVie has scored a major reduction of damages in a retrial of an AndroGel liability case. After a judge nixed the initial verdict of $150 million and sent the case back for retrial, a jury this week ...
ATLANTA (CN) - A federal judge dismissed the remaining claims in a nearly 10-year-old dispute over competition on AndroGel, a drug that boosts testosterone production. In the 1990s, Unimed ...
Androgel (testosterone) is a brand-name topical gel that’s prescribed for low testosterone due to certain medical conditions in adults. The cost of the drug with and without insurance can depend on ...
A federal jury on Monday ordered AbbVie to pay $3.2 million to an Oregon man who claims the testosterone replacement drug AndroGel caused him to suffer a heart attack, a far smaller penalty than the ...
(Bloomberg) — Abbott Laboratories and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claimed in lawsuits. Their ...
Case Name: FTC v. Actavis, Inc. (In re: Androgel Antitrust Litigation (II), Case No. 1:09-CV-955-TWT, 2014 U.S. Dist. LEXIS 54808 (N.D. Ga. Apr. 18, 2014) (Thrash, J ...
A federal-court jury in Chicago ordered drugmaker AbbVie Inc.ABBV-0.29%decrease; red down pointing triangle to pay $150 million in punitive damages to an Oregon man after finding the company liable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback